Stopped: Study was terminated by the sponsor due to low accrual.
The purpose of this study is to evaluate if pregabalin demonstrates significant reduction in abdominal pain from adhesions.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Absolute Adhesional Abdominal Pain Score Assessed at Baseline Through Week 12 in Patients Treated With Pregabalin 150-300 mg Daily Compared With Patients Given Look Alike Placebo
Timeframe: Baseline and week 2 through week 12